PLUS THERAPEUTICS, INC. — Director's Dealing 2023

Nov 15, 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: PLUS THERAPEUTICS, INC. (PSTV)
CIK: 0001095981
Period of Report: 2023-11-10

Reporting Person: Lenk Robert P (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2023-11-10	Common Stock	P	2000	$1.45	Acquired	19160	Direct
2023-11-13	Common Stock	P	4000	$1.43	Acquired	23160	Direct

Footnotes

F1: The price reported in column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.42 to $1.47 per share. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

F2: The price reported in column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.42 to $1.44 per share. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full
information regarding the number of shares purchased at each separate price within the range set forth in this footnote.